Publications by authors named "Howard Rutman"

Claim this Profile
A
Application of the Win Ratio Method in the ENGAGE AF-TIMI 48 Trial Comparing Edoxaban With Warfarin in Patients With Atrial Fibrillation.
Brian A Bergmark, Jeong-Gun Park, Rose A Hamershock, Giorgio E M Melloni, Raffaele De Caterina, Howard Rutman

Circ Cardiovasc Qual Outcomes· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Targeted Proteomic Approach Identifies Novel Biomarkers of Arterial Thromboembolic Risk in ENGAGE AF-TIMI 48.
David D Berg, Robert P Giugliano, Christian T Ruff, Minao Tang, KyungAh Im, Howard Rutman

J Am Coll Cardiol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between body mass index and outcomes in patients with atrial fibrillation treated with edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial.
Giuseppe Boriani, Christian T Ruff, Julia F Kuder, Minggao Shi, Hans J Lanz, Howard Rutman

Eur Heart J· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stroke prevention in atrial fibrillation: Closing the gap.
Sean D Pokorney, Bernard J Gersh, Azhar Ahmad, Sana M Al-Khatib, Melanie Blank, Howard Rutman

Am Heart J· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical events after interruption of anticoagulation in patients with atrial fibrillation: An analysis from the ENGAGE AF-TIMI 48 trial.
Ilaria Cavallari, Christian T Ruff, Francesco Nordio, Naveen Deenadayalu, Minggao Shi, Howard Rutman

Int J Cardiol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF-TIMI 48 Trial.
Alon Eisen, Christian T Ruff, Eugene Braunwald, Rose A Hamershock, Basil S Lewis, Howard Rutman

J Am Heart Assoc· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sudden Cardiac Death in Patients With Atrial Fibrillation: Insights From the ENGAGE AF-TIMI 48 Trial.
Alon Eisen, Christian T Ruff, Eugene Braunwald, Francesco Nordio, Ramón Corbalán, Howard Rutman

J Am Heart Assoc· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Edoxaban vs warfarin in patients with nonvalvular atrial fibrillation in the US Food and Drug Administration approval population: An analysis from the Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48 (ENGAGE AF-TIMI 48) trial.
Alon Eisen, Robert P Giugliano, Christian T Ruff, Francesco Nordio, Harinder S Gogia, Howard Rutman

Am Heart J· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Edoxaban vs. warfarin in vitamin K antagonist experienced and naive patients with atrial fibrillation†.
Michelle L O'Donoghue, Christian T Ruff, Robert P Giugliano, Sabina A Murphy, Laura T Grip, Howard Rutman

Eur Heart J· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ivermectin versus malathion for head lice.
Howard Rutman

N Engl J Med· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of essential tremor with the barbiturate T2000 (1,3-dimethoxymethyl-5,5-diphenyl-barbituric acid).
Calvin Melmed, Daniel Moros, Howard Rutman

Mov Disord· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis